18 F-fluorodeoxyglucose positron emission tomography-computed tomography is commonly used for the staging of non-small-cell lung carcinoma. However, few studies have investigated the correlation between the maximum standardised uptake value (SUV max ) of the primary tumour and the disease staging according to histology. The current retrospective study evaluated this relationship using statistical analyses. The findings suggest that higher SUV max is positively correlated with more advanced staging. This study demonstrates the importance of SUV max interpretation on the radiological staging of non-small-cell lung carcinoma.
INTRODUCTION
The treatment and prognosis of non-small-cell lung carcinoma (NSCLC) heavily depends on accurate tumour, node, and metastasis (TNM) staging.
1-3 The (CT) 4, 5 or magnetic resonance imaging (MRI). 6, 7 In addition to TNM staging, the maximum standardised uptake value (SUV max ) of the primary tumour has been suggested as a prognostic factor for postoperative mortality, 8 recurrence, 9, 10 and survival. 8, [11] [12] [13] [14] However, few studies have performed statistical analyses on the correlation between SUV max and TNM staging. Furthermore, previous studies have typically assessed the SUV max irrespective of histology.
14 Yet SUV max depends on histology, with larger values of SUV max in squamous cell carcinoma (SCC) than in adenocarcinoma.
14 The aim of the current study was to clarify the relationship between the SUV max of the primary tumour and staging in NSCLC through statistical evaluation and subgroup analyses according to histology.
METHODS

Patients
In this retrospective study, patients with newly diagnosed biopsy-proven NSCLC who underwent PET-CT staging at the Nuclear Medicine Unit and Clinical PET Centre, Queen Elizabeth Hospital, Hong Kong from January 2016 to January 2017 were included. If PET-CT showed localised disease, thoracic lymph nodes were sampled by cardiothoracic surgeons or respiratory physicians within 2 months via lobectomy, mediastinoscopy, video-assisted thoracoscopic surgery, endobronchial ultrasound, pneumonectomy, or wedge resection. Histology was evaluated by pathologists according to the Mountain and Dresler scheme.
15 If PET-CT suggested distant metastases, histological or radiological investigations (including CT, MRI, bone scan, and X-ray) were supplemented to support the diagnosis of distant metastases. Patients were excluded if oncological treatment was started before PET-CT or if blood glucose was >12 mmol/L at the time of PET-CT acquisition.
Positron Emission Tomography and Computed Tomography
The 18 F-FDG PET-CT imaging was performed with a dedicated scanner (Discovery 710, General Electric, Wisconsin, US) in accordance to the 2010 procedural protocol of European Association of Nuclear Medicine for oncological PET acquisition. 16 The mean Throughout this study, the SUV max of only the primary tumour was used. In case of multiple intrapulmonary tumours, the one with the highest SUV max was taken.
Statistical Analyses
The SUVs max were categorised into three groups for analysis based on PET-CT: non-metastatic (ie, without nodal/distant metastases); nodal metastatic (ie, with biopsy-proven nodal metastasis in ipsilateral peribronchial, ipsilateral hilar, ipsilateral mediastinal or subcarinal basin but no distant metastases); and distant metastatic (ie, lung nodule in contralateral lobe, pleural nodule, pleural or pericardial effusion, or extrathoracic organs). Within each group, the SUVs max were further evaluated according to pathology: all histologies, adenocarcinoma, or SCC. Two-sided Student's t tests were performed to compare the SUVs max between groups.
RESULTS
Patient Characteristics
A total of 206 patients (144 men and 62 women; age range, 42-86 years) were analysed, with the characteristics of study population summarised in Table  1 . In total, 68.4% of patients had adenocarcinoma, 19.9% had SCC, and 12.6% had other pathology (eg, adenosquamous carcinoma, poorly differentiated NSCLC, lymphoepithelioma-like carcinoma, large-cell carcinoma). In all, 26.2% of patients were included in the non-metastatic group, 17.5% in the nodal metastatic group, and 56.3% in the distant metastatic group. Figure 1 shows typical SUV appearances in maximum intensity projection images for adenocarcinoma for the non-, nodal, and distant metastatic groups. Table  2 shows the mean SUVs max for the different groups.
Maximum Standardised Uptake Value Analysis
Variations in SUV max were observed even for the same stage and histology. Thus, the distribution of SUV max is best expressed statistically as a cumulative fraction curve against SUV max (ie, the number of patients in a group with SUV max less than the specific magnitude divided by total number of patients in the group). The cumulative fractions against SUV max for all histologies, only adenocarcinoma, and only SCC are shown in Figure 2 .
Group Comparison
The SUVs max of different groups were compared using Student's t test, with the corresponding p values listed in Table 3 .
DISCUSSION
A high SUV max for the primary tumour in NSCLC has previously been described as a poor prognostic factor for postoperative mortality, 8 disease-free survival, 
(a) (b) (c) (d)
recurrence, 9,10 and distant metastases-free survival.
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However, few studies have provided statistical analysis of SUV max between non-, nodal, and distant metastatic groups. In addition, few studies have evaluated SUV max according to histology. Histology-based SUV max analysis is important; the results of the current study show that the SUV max for SCC is greater than that of adenocarcinoma, consistent with the literature.
14 The current study also shows that more advanced disease is correlated with greater SUV max . Qualitative examples, such as the maximum intensity projection images shown in Figure 1 , indicate that primary tumours have a greater uptake for more aggressive disease. Even for the distant metastatic group, SUV max was greater for more extensive metastases, as shown in Figure 1c and d. Quantitative analyses in Figure 2 and Table 3 verify that SUV max rank highest for the distant, followed by nodal and non-metastatic groups for all histologies and adenocarcinoma, with p<0.05. For example, Figure 2b shows that only 17% of non-metastatic adenocarcinoma have SUV max >10, whereas 35% of nodal and 50% of distant metastatic adenocarcinoma have SUV max >10. This finding has an important clinical implication: high SUV max should raise clinician's suspicion of nodal or distant metastases. Figure 3a shows the maximum intensity projection image of a patient newly diagnosed with adenocarcinoma of lung. Two hypermetabolic nodules are noted over the right upper lobes (SUV max 15.6 and 4.1), together with a mildly hypermetabolic right interlobar lymph node. Otherwise, there is no definite evidence of distant metastases from skull base to midthigh. In view of the radiological T3N1 disease, radical surgery may be offered. However, for the non-and nodal metastatic groups, only 5% have primary SUV max ≥15.6, whereas for the metastatic group, 20% have primary SUV max ≥15.6 (Figure 2b) . Thus, distant metastases should be suspected of in view of the high SUV max .
A common metastatic site of lung adenocarcinoma is in the brain, which may be missed in PET-CT. For this patient, brain MRI was offered, revealing multiple cerebral metastases (representative image in Figure  3b) . The patient subsequently received palliative Table 3 . P values of two-tailed Student's t tests in the comparisons of non-metastatic versus nodal metastatic, nodal versus distant metastatic, and adenocarcinoma versus squamous cell carcinoma groups, with subgroup analyses as listed.
radiotherapy and chemotherapy. This example illustrates the importance of interpreting high SUV max . In contrast, low SUV max magnitude implies a lower likelihood for nodal or distant metastases. Figure 4a shows the maximum intensity projection image of another patient with two hypermetabolic nodules at right lower and upper lobes (SUVs max of 7.8 and 7.0), without definite evidence of nodal or distant metastases. The differentials include double primaries or intrapulmonary metastases. Correct radiological staging is critical here to determine if treatment intent is curative or palliative. Although certain morphological features may help distinguish the two differentials, the features have significant overlap between different histological types. 19 The current study suggests that a tumour with a low SUV max is less likely than a tumour with a high SUV max to have nodal or distant involvement. Based on Figure 2b , primary SUV max is ≤7 in 70% of non-metastatic adenocarcinoma, but in only 20% of distant metastatic adenocarcinoma. Thus, the radiological findings suggest double primaries. The patient eventually underwent radical right upper and lower lobe lobectomy. Final pathology confirmed this diagnosis, with one lesion having wild-type epidermal growth factor receptor and the other mutated epidermal growth factor receptor. The results of the current study show that SUV max interpretation is also important for risk stratification of nodal and distant metastasis. Figure  2b indicates that, for example, 80% risks in nodal and distant metastasis correspond to SUV max cut-offs of 12 and 14, respectively. However, exact SUVs max depend on many factors.
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For SCC, the results of current study show that the distant metastatic group generally has higher SUV max than non-and nodal metastatic groups (Table 2 and Figure 2c ). However, the differences are not statistically significant (p=0.97 for non-metastatic compared with nodal metastatic groups; p=0.167 for nodal metastatic compared with distant metastatic groups), probably owing to the low number of SCC cases included compared with all histologies and adenocarcinoma (41 vs 206 and 141, respectively; Table 1 ).
A previous study suggested that the SUV max in SCC is generally higher than that in adenocarcinoma, although corresponding disease extent was not well clarified. 21 The findings of the current study suggest that SUV max depends on the disease extent. Our study also confirms that the SUV max in SCC is higher than that in adenocarcinoma for the non-, nodal, and distant metastatic groups (Tables 2  and 3 ). However, the difference in the nodal group was not statistically significant (p=0.16), likely owing to the low number of SCC cases.
CONCLUSION
The current retrospective study investigated the SUV max of primary NSCLC tumours. The SUV max was found to be dependent on TNM staging, and was highest in the distant metastatic group and lowest in the non-metastatic group. The application of SUV max interpretation to radiological staging was demonstrated through examples.
